The study aimed to evaluate the association between retinopathy of prematurity (ROP) and hearing loss in preterm infants.
✦ The floor
Discussion
Signed responses from readers of the wire.
Clinicians caring for preterm infants who required ROP treatment should be aware of a potential association with hearing loss, supporting thorough audiology follow-up screening in this population; however, the retrospective design limits causal conclusions.
Identifying co-occurrence of ROP treatment and hearing loss in preterm infants could help prioritize high-risk neonates for early audiology screening and multidisciplinary follow-up.
- 01Retrospective design examining hearing loss rates in preterm infants who needed ROP treatment.
- 02Both ROP and hearing loss share common risk factors in prematurity (e.g., low gestational age, NICU interventions).
- 03Findings may support integrated screening protocols for preterm infants with severe ROP.
- 04Published in American Journal of Otolaryngology (2026).
- 05Causal direction cannot be established from a retrospective study.
Treatment-requiring retinopathy of prematurity is associated with hearing loss in preterm infants.
studypartially supported- PMID
- 42208094
- DOI
- 10.1016/j.amjoto.2026.104861.
- Journal
- American Journal of Otolaryngology
- Publication type
- research_article
- Evidence level
- 4
- Population
- Preterm infants with treatment-requiring retinopathy of prematurity
- Intervention
- Presence of treatment-requiring retinopathy of prematurity
- Comparator
- Preterm infants without treatment-requiring ROP
Primary outcomes
Prevalence/association of hearing loss in preterm infants with treatment-requiring ROP